Establishment of a pilot pediatric registry for chronic vasculitis is both essential and feasible: A Childhood Arthritis and Rheumatology Alliance (CARRA) survey

Journal of Rheumatology

Volumn 34, Issue 1, 2007, Pages 224-226

  Wilkinson, Nicholas M R ^a,b   Page, Jacqueline ^a   Uribe, América G ^a   Espinosa, Victor ^a   Cabral, David A ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^c BC CHILDREN S HOSPITAL   (Canada)

Author keywords

Chronic vasculitis; Pediatric; Registry

Indexed keywords

AORTA ARCH SYNDROME; ARTHRITIS; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; HEALTH SURVEY; MICROSCOPIC POLYANGIITIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; REVIEW; VASCULITIS; WEGENER GRANULOMATOSIS;

ADOLESCENT; CANADA; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEASIBILITY STUDIES; HEALTH SURVEYS; HUMANS; NEEDS ASSESSMENT; PILOT PROJECTS; POLYARTERITIS NODOSA; PROSPECTIVE STUDIES; REGISTRIES; RHEUMATOLOGY; TAKAYASU'S ARTERITIS; UNITED STATES; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 33846216032     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Belostotsky VM, Shah V, Dillon MJ. Clinical features in 17 paediatric patients with Wegener granulomatosis. Pediatr Nephrol 2002;17:754-61.
2. Rottem M, Fauci AS, Hallahan CW, et al. Wegener granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr 1993;122:26-31.
3. Yu F, Huang J-P, Zou WZ, Zhao M-H. The clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in Chinese children. Pedriatr Nephrol 2006;21:497-502.
4. Hattori M, Kurayama H, Koitabashi Y. Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in children. J Am Soc Nephrol 2001;12:1493-500.
5. Ozen S, Anton J, Arisoy N, et al. Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr 2004;145:517-22.
6. Ozen S, Bakkaloglu A, Dusunsel R, et al. Childhood vasculitis in Turkey: a nationwide survey. Clin Rheumatol 2006 [Epub ahead of print].
7. Malleson PN, Fung MY, Rosenberg AM. The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheumatology Association Disease Registry. J Rheumatol 1996;23:1981-7.
8. Bowyer S, Roettcher P. Pediatric rheumatology clinic populations in the United States: results of a 3 year survey. Pediatric Rheumatology Database Research Group. J Rheumatol 1996;23:1968-74.
9. Hoffman GS. Classification of the systemic vasculitides: antineutrophil cytoplasmic antibodies, consensus and controversy. Clin Exp Rheumatol 1998;16:111-5.
10. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
11. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
12. Ozen S, Ruperto N, Dillon M, et al. EULAR/PRES Endorsed Consensus Criteria for the Classification of Childhood Vasculitides. Ann Rheum Dis 2006;65:936-41.
13. Newton J. Disease registers in England. Oxford: Institute of Health Sciences, Oxford University; 2002.
14. Sebaldt RJ, Kremer JM. CANDOO and CANOAR, CORRONA and more: advancing therapeutics through layered-in clinical data collection and feedback at the point of care. J Rheumatol 2003;30:2308-11.
15. Mayes MD, Giannini EH, Pachman LM, Buyon JP, Fleckman P. Connective tissue disease registries. Arthritis Rheum 1997;40:1556-9.